These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8575585)

  • 1. Predictive value of serum III procollagen for diagnosis of pulmonary involvement in patients with scleroderma.
    Diot E; Diot P; Valat C; Boissinot E; Asquier E; Lemarie E; Guilmot JL
    Eur Respir J; 1995 Sep; 8(9):1559-65. PubMed ID: 8575585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procollagen Type I and III Aminoterminal Propeptide Levels and Severity of Interstitial Lung Disease in Mexican Women With Progressive Systemic Sclerosis.
    Gonzalez-Lopez L; Rocha-Muñoz AD; Olivas-Flores EM; Garcia-Gonzalez A; Peguero-Gómez AR; Flores-Navarro J; Villa-Manzano AI; Zavaleta-Muñiz SA; Salazar-Paramo M; Mejía M; Juárez-Contreras P; Vazquez-Del Mercado M; Cardona-Muñoz EG; Trujillo-Hernández B; Nava-Zavala AH; Gamez-Nava JI
    Arch Bronconeumol; 2015 Sep; 51(9):440-8. PubMed ID: 25301411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased serum COMP predicts mortality in SSc: results from a longitudinal study of interstitial lung disease.
    Hesselstrand R; Andréasson K; Wuttge DM; Bozovic G; Scheja A; Saxne T
    Rheumatology (Oxford); 2012 May; 51(5):915-20. PubMed ID: 22253028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esophageal involvement and pulmonary manifestations in systemic sclerosis.
    Marie I; Dominique S; Levesque H; Ducrotté P; Denis P; Hellot MF; Courtois H
    Arthritis Rheum; 2001 Aug; 45(4):346-54. PubMed ID: 11501722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procollagen-III peptide and chronic viral C hepatitis.
    Jeffers LJ; Coelho-Little ME; Cheinquer H; Vargas C; Civantos F; Alvarez L; Reddy KR; Parker T; de Medina M; Li X
    Am J Gastroenterol; 1995 Sep; 90(9):1437-40. PubMed ID: 7661165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between abnormalities on high-resolution CT and pulmonary function in systemic sclerosis.
    Diot E; Boissinot E; Asquier E; Guilmot JL; Lemarié E; Valat C; Diot P
    Chest; 1998 Dec; 114(6):1623-9. PubMed ID: 9872198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum aminoterminal propeptide of type III procollagen in systemic sclerosis. A follow-up--investigations in subclasses and during therapy.
    Heickendorff L; Parvez A; Bjerring P; Halkier-Sørensen L; Zachariae H
    Acta Derm Venereol; 1991; 71(3):185-8. PubMed ID: 1678217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type III collagen aminopropeptide levels in serum of patients with progressive systemic scleroderma.
    Krieg T; Langer I; Gerstmeier H; Keller J; Mensing H; Goerz G; Timpl R
    J Invest Dermatol; 1986 Dec; 87(6):788-91. PubMed ID: 3782862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of serum levels of laminin, type IV collagen, procollagen III N-terminal peptide, and hyaluronic acid with the progression of interstitial lung disease.
    Su Y; Gu H; Weng D; Zhou Y; Li Q; Zhang F; Zhang Y; Shen L; Hu Y; Li H
    Medicine (Baltimore); 2017 May; 96(18):e6617. PubMed ID: 28471958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.
    Muangchan C; Harding S; Khimdas S; Bonner A; ; Baron M; Pope J
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1405-14. PubMed ID: 22556030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum aminoterminal propeptide of type III procollagen in progressive systemic sclerosis and localized scleroderma.
    Zachariae H; Halkier-Sørensen L; Heickendorff L
    Acta Derm Venereol; 1989; 69(1):66-70. PubMed ID: 2563612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum III procollagen, but not serum I procollagen, is predictive of lung involvement in systemic sclerosis.
    Valat C; Diot E; Diot P
    Clin Exp Rheumatol; 1998; 16(4):517-8. PubMed ID: 9706450
    [No Abstract]   [Full Text] [Related]  

  • 13. [The clinical study on KL-6 and SP-D in sera of patients with various pulmonary diseases].
    Sugimoto H; Okada E; Hashimoto N; Suzuki S; Yoshida H; Totani Y; Ameshima S; Ishizaki T; Miyamori I
    Rinsho Byori; 2000 Jun; 48(6):554-60. PubMed ID: 10897675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbohydrate antigen 15.3 as a serum biomarker of interstitial lung disease in systemic sclerosis patients.
    Celeste S; Santaniello A; Caronni M; Franchi J; Severino A; Scorza R; Beretta L
    Eur J Intern Med; 2013 Oct; 24(7):671-6. PubMed ID: 23697634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is anti-topoisomerase I a serum marker of pulmonary involvement in systemic sclerosis?
    Diot E; Giraudeau B; Diot P; Degenne D; Ritz L; Guilmot JL; Lemarié E
    Chest; 1999 Sep; 116(3):715-20. PubMed ID: 10492277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired carbon monoxide diffusing capacity as a marker of limited systemic sclerosis.
    Trad S; Huong du LT; Frances C; Wechsler B; Cacoub P; Costedoat N; Haroche J; Piette JC; Hanslik T; Amoura Z
    Eur J Intern Med; 2011 Dec; 22(6):e80-6. PubMed ID: 22075318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
    Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
    Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of serum collagen I carboxyterminal telopeptide concentrations with cutaneous and pulmonary involvement in systemic sclerosis.
    Allanore Y; Borderie D; Lemaréchal H; Cherruau B; Ekindjian OG; Kahan A
    J Rheumatol; 2003 Jan; 30(1):68-73. PubMed ID: 12508392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the functional parameters in scleroderma cases with pulmonary involvement.
    Celebi Sözener Z; Karabıyıkoğlu G; Düzgün N
    Tuberk Toraks; 2010; 58(3):235-41. PubMed ID: 21038133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the aminoterminal peptide of procollagen type III and laminin P1 in serum of patients with chronic liver disease.
    Kárteszi M; Szalay L; Cornides A; Dávid K; Fehér J
    Acta Med Hung; 1988; 45(3-4):277-86. PubMed ID: 3249655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.